vMap® Clinical Studies
The vMap Study
Forward-solution Computational Arrhythmia
Blinded, multi-center, and independently adjudicated
Atrial and ventricular arrhythmias were studied, as well as pacing
Hypothesis: vMap can help identify the locations of arrhythmias and pacing
vMap compared to ’gold standard’ site of successful ablation or pacing during EP study and ablation
The vMap Time Study
Forward-Solution Computational Arrhythmia Mapping is Associated with Decreased Procedural Time, Fluoroscopy Use, and Cost.
In 2022, an objective, retrospective study was undertaken to compare the first 30 ablation procedures using vMap with the prior 30 matched, pre- vMap procedures.
Use of vMap was also associated with a reduced use of 64-electrode basket catheters in atrial fibrillation ablation cases.
Radio-Ablation Planning Study Utilizing vMap
Computational ECG mapping and respiratory gating to optimize stereotactic ablative radiotherapy workflow for refractory ventricular tachycardia.
This peer-reviewed article concluded that vMap and protocol-based respiratory gating may help facilitate radioablation planning and maintain efficacy during therapy.
The prospective, dual-site study reported that a new non-invasive workflow using vMap™ may help facilitate the radioablation planning workflow. The study concluded that radio-ablation using vMap’s 12-lead ECG mapping and respiratory gated delivery may provide short-term safety and maintain efficacy during therapy in patients with advanced structural heart disease and refractory ventricular tachycardia.*